So-Young International (NASDAQ:SY) Issues Earnings Results, Beats Estimates By $0.03 EPS

So-Young International (NASDAQ:SY) issued its quarterly earnings data on Friday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.03, Zacks reports. So-Young International had a negative return on equity of 12.54% and a negative net margin of 15.97%.The business had revenue of $62.77 million during the quarter, compared to analyst estimates of $60.20 million.

Here are the key takeaways from So-Young International’s conference call:

• So-Young reported Q1 2026 revenue of RMB 432.8 million, up 45.6% year over year, with aesthetic treatment services revenue rising 185.8% to RMB 282.4 million and exceeding the high end of guidance for the fourth straight quarter.
• The company’s clinic chain continued to scale quickly, reaching 59 centers across 17 cities by today, with Q1 treatment visits up 172% year over year and verified treatments up 164% year over year.
• Unit economics improved further, with 41 centers profitable and 48 generating positive operating cash flow in Q1. Management also said the aesthetic center business gross margin reached 27%, reflecting better operating efficiency.
• Management highlighted strong user engagement, including core members above 63,000 and referral-sourced new customers rising to 52% of the mix, while emphasizing that CAC remained well controlled.
• The company raised its supply-chain and product strategy, including an exclusive partnership with Jinbo Bio-Pharmaceutical and the launch of Miracle Collagen, while blockbuster products such as BBL and Thermage lifted blockbuster-product revenue contribution to 41% of Q1 sales.

So-Young International Stock Performance

Shares of NASDAQ SY opened at $2.23 on Friday. The stock has a fifty day moving average price of $2.86 and a two-hundred day moving average price of $3.00. The firm has a market cap of $226.19 million, a P/E ratio of -6.76 and a beta of 2.10. So-Young International has a 1 year low of $0.82 and a 1 year high of $6.28.

Hedge Funds Weigh In On So-Young International

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SY. Barclays PLC boosted its stake in So-Young International by 124.3% during the 4th quarter. Barclays PLC now owns 1,116,336 shares of the company’s stock valued at $2,858,000 after purchasing an additional 618,709 shares in the last quarter. Nomura Holdings Inc. bought a new position in So-Young International during the 3rd quarter valued at $1,265,000. Lighthouse Investment Partners LLC bought a new position in So-Young International during the 3rd quarter valued at $1,105,000. Quadrature Capital Ltd bought a new position in So-Young International during the 3rd quarter valued at $1,080,000. Finally, Schonfeld Strategic Advisors LLC bought a new position in So-Young International during the 3rd quarter valued at $663,000. 35.31% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Weiss Ratings lowered So-Young International from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, April 27th. Wall Street Zen raised So-Young International from a “sell” rating to a “hold” rating in a report on Sunday, April 26th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $5.50.

So-Young International Company Profile

So-Young International Inc operates a leading digital marketplace and community platform focused on the medical aesthetic industry in China. Headquartered in Shanghai and founded in 2013, the company connects consumers seeking cosmetic treatments with a network of accredited clinics, licensed physicians and beauty service providers. Its online ecosystem offers a wealth of educational content, peer reviews and before-and-after galleries designed to help users make informed decisions about aesthetic procedures.

The company’s platform is accessible via web and mobile applications, where users can browse service packages, compare providers, read expert articles and schedule appointments directly through an integrated booking system.